NEVRO CORP. Current Foreign Tax Expense (Benefit)
NEVRO CORP. reported Current Foreign Tax Expense (Benefit) of $912.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2025-03-04
- NEVRO CORP. current foreign tax expense (benefit) for fiscal 2024 was $912.00K, a 9.22% increase from fiscal 2023.
- NEVRO CORP. current foreign tax expense (benefit) for fiscal 2023 was $835.00K, a 3.21% increase from fiscal 2022.
- NEVRO CORP. current foreign tax expense (benefit) for fiscal 2022 was $809.00K, a 38.29% increase from fiscal 2021.
- NEVRO CORP. current foreign tax expense (benefit) for fiscal 2021 was $585.00K, a 10.82% decline from fiscal 2020.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | $912.00K 10-K · filed 2025-03-04 |
| 2023-12-31 | $835.00K 10-K · filed 2025-03-04 |
| 2022-12-31 | $809.00K 10-K · filed 2025-03-04 |
| 2021-12-31 | $585.00K 10-K · filed 2024-02-23 |
| 2020-12-31 | $656.00K 10-K · filed 2023-02-21 |
| 2019-12-31 | $1.64M 10-K · filed 2022-02-23 |
| 2018-12-31 | $1.48M 10-K · filed 2021-02-24 |
| 2017-12-31 | $1.24M 10-K · filed 2020-02-25 |
| 2016-12-31 | $1.44M 10-K · filed 2019-02-21 |
| 2015-12-31 | $1.13M 10-K · filed 2018-02-22 |
| 2014-12-31 | $476.00K 10-K · filed 2017-02-23 |
| 2013-12-31 | $368.00K 10-K · filed 2016-02-29 |
| 2012-12-31 | $167.00K 10-K · filed 2015-03-18 |